ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Invesco Dorsey Wright Healthcare Momentum ETF
61.53
-0.4974
-0.80%
成交量:
1,826
成交額:
11.25萬
市值:
2.89億
市盈率:
20.13
高:
62.20
開:
62.20
低:
61.37
收:
62.02
52周最高:
64.10
52周最低:
39.76
股本:
470.00萬
流通股本:
470.00萬
量比:
0.34
換手率:
0.04%
股息:
1.53
股息率:
2.48%
每股收益(TTM):
3.06
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准,這是首款針對胰腺
智通财经
·
08/26
《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果
美股速递
·
08/26
美國食品藥品監督管理局(FDA)批准了Revolution Medicines公司的一款胰腺癌藥物
路透中文
·
08/26
江蘇:推動相關縣聚焦創新藥和高端醫療器械等產業,建立「N個1」培育機制,因地制宜發展特色優勢產業
智通财经
·
08/26
江蘇:加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業
智通财经
·
08/26
採納股份:全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證
智通财经
·
08/26
三力製藥在陝西成立藥品銷售新公司
智通财经
·
08/26
康拓醫療:控股子公司取得第三類醫療器械註冊證
智通财经
·
08/25
步長製藥等成立新公司 註冊資本5000萬元
智通财经
·
08/25
【券商聚焦】中信建投:醫療器械板塊估值正在重構
金吾财讯
·
08/25
美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元
路透中文
·
08/24
Twinstrand:法院判決公司及Uw獲賠逾2.452億美元,涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息
美股速递
·
08/24
Twinstrand勝訴:法院維持2023年故意侵權判決,並裁定Guardant Health 11項產品與服務須支付6%特許權使用費
美股速递
·
08/24
Twinstrand案判決:Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細
美股速递
·
08/24
Twinstrand:特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴
美股速递
·
08/24
印度提議修改醫療器械規則。
智通财经
·
08/24
新產業:獲得血管緊張素轉化酶測定試劑盒醫療器械註冊證
智通财经
·
08/24
萬孚生物:取得7項化學發光類醫療器械註冊證
智通财经
·
08/23
翔宇醫療激光毫米波治療儀獲國家醫療器械註冊證
智通财经
·
08/23
貴州公布13起典型案例
贵阳日报
·
08/21
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/PTH/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":61.525,"timestamp":1789740694736,"preClose":62.0224,"halted":0,"volume":1826,"delay":0,"changeRate":-0.008019683211226895,"floatShares":4700000,"shares":4700000,"eps":3.057033,"marketStatus":"交易中","change":-0.4974,"latestTime":"09-18 10:12:18 EDT","open":62.1967,"high":62.1967,"low":61.365,"amount":112497.325512,"amplitude":0.01341,"askPrice":61.59,"askSize":600,"bidPrice":61.37,"bidSize":800,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.0224,"sharesOutstanding":2480000,"nav":60.77493,"aum":287465418.9,"dividendRate":0.024798,"bidAskSpread":0.00195,"preHourTrading":{"tag":"盘前","latestPrice":62.0224,"preClose":62.0224,"latestTime":"04:00 EDT","volume":1,"amount":62.0224,"timestamp":1789718420500,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":62.01,"preClose":62.0224,"latestTime":"19:30 EDT","volume":10,"amount":619.8306,"timestamp":1789687804886,"change":-0.0124,"changeRate":-0.0002,"amplitude":0},"volumeRatio":0.341291,"impliedVol":0.0816,"impliedVolPercentile":0.2191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.341291,"shares":4700000,"dividePrice":1.5257,"high":62.1967,"amplitude":0.01341,"preClose":62.0224,"low":61.365,"week52Low":39.76,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":61.525,"committee":0.142857,"eps":3.057033,"divideRate":0.024798,"volume":1826,"delay":0,"ttmEps":3.057033,"open":62.1967,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":60.7692,"twentyDayClose":62.111,"sixtyDayClose":55.6532},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662482997","title":"Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准,這是首款針對胰腺","url":"https://stock-news.laohu8.com/highlight/detail?id=2662482997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662482997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:14","pubTimestamp":1787757271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RVMD","IE0009354923.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4139","IDNA","BBH","PTH","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","IE0009355771.USD","CANC","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169456208","title":"《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169456208","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169456208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:12","pubTimestamp":1787757130,"startTime":"0","endTime":"0","summary":"《JAMA皮肤病学》杂志正式刊发了Brepocitinib在皮肌炎治疗中的3期VALOR试验皮肤特异性结局数据。这项研究聚焦于皮肤相关症状的改善情况,为这一罕见自身免疫性疾病的治疗提供了新的临床证据。该试验结果此前已引起业界广泛关注,如今皮肤特异性数据的公布,进一步丰富了人们对Brepocitinib疗效维度的理解。皮肌炎以皮肤和肌肉炎症为特征,皮肤表现往往对患者生活质量造成显著影响,因此这一数据的发布具有重要临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271008","title":"美國食品藥品監督管理局(FDA)批准了Revolution Medicines公司的一款胰腺癌藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271008","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662271008?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 22:44","pubTimestamp":1787755452,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)批准了Revolution Medicines公司的一款胰腺癌药物路透8月26日-美国食品药品监督管理局周三表示,已批准Revolution Medicines公司用于治疗转移性胰腺癌的靶向药物RVMD.O。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4T44N176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","IDNA","IE0002141913.USD","IE00B4R5TH58.HKD","PTH","IE0009354923.USD","BBH","BK4139","IE00BJT1NW94.SGD","IE00B2B36J28.USD","CANC","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662471794","title":"江蘇:推動相關縣聚焦創新藥和高端醫療器械等產業,建立「N個1」培育機制,因地制宜發展特色優勢產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662471794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662471794?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","LNGR","PTH","RSPH","MEDX","IEIH","IBBQ","MDEV","GDOC","HART","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779444","title":"江蘇:加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779444","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662779444?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","LNGR","HART","MEDX","PTH","IEIH","AGNG","RSPH","GDOC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795505","title":"採納股份:全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795505?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 15:59","pubTimestamp":1787731173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MDEV","MEDX","LNGR","HART","GDOC","AGNG","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276595","title":"三力製藥在陝西成立藥品銷售新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276595?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 08:53","pubTimestamp":1787705590,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","RSPH","PTH","LGHT","LNGR","AGNG","GDOC","MEDX","IEIH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808847","title":"康拓醫療:控股子公司取得第三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808847?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 17:13","pubTimestamp":1787649205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MEDX","HART","PTH","GDOC","MDEV","LNGR","RSPH","LGHT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788168","title":"步長製藥等成立新公司 註冊資本5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662788168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 11:09","pubTimestamp":1787627361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","LNGR","PTH","RSPH","MEDX","IEIH","MDEV","GDOC","HART","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705207","title":"【券商聚焦】中信建投:醫療器械板塊估值正在重構","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705207","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705207?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:32","pubTimestamp":1787621521,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,建议2026年加配医疗器械板块,短期来看,建议把握2026年业绩改善个股的业绩和估值修复机会,高值耗材和IVD板块的集采或降价影响将于下半年逐步出清,多家细分赛道龙头将于2026年迎来加速增长,同时建议关注手术机器人、脑机接口等新科技方向,相关技术突破和商业化落地有望持续催化板块热度。长期来看,医疗器械板块投资机会来自创新、出海和并购整合,板块的创新和国际化能力得到认可,估值正在重构。风险提示:行业政策风险、研发不及预期风险、审批不及预期风险、宏观环境波动风险、中东地缘政治风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","BK1571","06826","BK1615","01066","MEDX","BK1189","GDOC","MDEV","BK1589","159883","BK0276","HART","BK1617","BK1142","RSPH","BK1515","BK1501","LU0287142896.SGD","BK1593","HK0000165453.HKD","00241","BK1247","BK1585","09996","BK1574","BK1591","02190","AGNG","BK1100","KCE","BK1161","00853","LNGR","BK1584","BK1610","02252","LU0173614495.USD","PTH","02235","BK1587","BK1583","01302","BK1600","BK1222","BK1502","LGHT","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227372","title":"美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227372","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227372?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:21","pubTimestamp":1787570491,"startTime":"0","endTime":"0","summary":"美国法院在DNA测序专利纠纷案中裁定Guardant公司支付2.45亿美元路透8月24日-TwinStrand Biosciences周一表示,美国一家法院裁定Guardant Health公司侵犯了涉及DNA测序技术的专利,并责令其向TwinStrand Biosciences和华盛顿大学支付超过2.452亿美元的赔偿金。法院裁定,Guardant必须就其11项被认定侵犯专利的产品及服务在美国的销售额,支付6%的专利使用费,直至2033年3月相关专利到期为止。TwinStrand表示,该判决所涵盖的产品和服务约占Guardant在侵权期间总收入的90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4585","EKG","GDOC","GNOM","BK4551","PTH","BK4196","BK4535","LFSC","FFOX","HELX","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160211496","title":"Twinstrand:法院判決公司及Uw獲賠逾2.452億美元,涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息","url":"https://stock-news.laohu8.com/highlight/detail?id=1160211496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160211496?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569302,"startTime":"0","endTime":"0","summary":"Twinstrand公告,法院已作出裁决,判令公司及Uw获得超过2.452亿美元的赔偿金。这笔款项涵盖了截至2026年5月31日期间所发生的侵权损害、累积的特许权使用费以及相应利息。\n裁决金额之巨,彰显了司法体系对知识产权保护的坚定立场。赔偿总额精确计算至该截止日期,包括了多层次的补偿要素。侵权行为的认定范围,则明确划定在2026年5月31日之前发生的全部相关行为。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","LU0889565916.HKD","BK4196","GH","LFSC","GNMX","EKG","BK4588","GDOC","FFOX","LU0320765992.SGD","BK4585","HELX","GNOM","PTH","LU0109394709.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194764905","title":"Twinstrand勝訴:法院維持2023年故意侵權判決,並裁定Guardant Health 11項產品與服務須支付6%特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1194764905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194764905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569276,"startTime":"0","endTime":"0","summary":"法院裁定,维持2023年关于故意侵权的判决,同时要求Guardant Health公司就其11项产品及服务所产生的销售额,向Twinstrand支付6%的特许权使用费。这一裁决意味着,Twinstrand在知识产权纠纷中取得了关键性胜利。对于Guardant Health而言,这项决定无疑构成了财务上的重大负担。Twinstrand方面则对这一结果表示认可。此次6%特许权使用费的设定,亦反映了法院对此类行为的态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","GNOM","BK4588","LU0320765992.SGD","LU0889565916.HKD","BK4551","FFOX","BK4585","HELX","LU0109394709.USD","BK4196","BK4535","GNMX","PTH","GH","LFSC","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127912643","title":"Twinstrand案判決:Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127912643?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息,法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目,以供公司与承销商查阅。\n这一判决意味着,Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言,公司需定期整理并呈报相关销售数据,确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角,去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立,或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","LFSC","BK4196","BK4588","BK4535","LU0320765992.SGD","LU0109394709.USD","PTH","BK4551","GDOC","EKG","FFOX","GH","GNOM","HELX","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136746995","title":"Twinstrand:特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=1136746995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136746995?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"Twinstrand宣布,特拉华州法院已于8月21日作出判决,支持公司及华盛顿大学的立场,认定其在针对Guardant Health提起的专利侵权诉讼中占据优势。这一裁决标志着这场备受关注的法律纠纷取得了阶段性胜利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","BK4585","BK4588","BK4535","LU0109394709.USD","GH","LU0320765992.SGD","GDOC","FFOX","GNMX","HELX","BK4551","GNOM","LU0889565916.HKD","PTH","BK4196","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246882","title":"印度提議修改醫療器械規則。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246882?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 16:53","pubTimestamp":1787561605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","PTH","LNGR","IEIH","AGNG","MDEV","MEDX","HART","LGHT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291662","title":"新產業:獲得血管緊張素轉化酶測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291662?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 15:56","pubTimestamp":1787558209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","RSPH","MDEV","HART","LNGR","IEIH","PTH","AGNG","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210916","title":"萬孚生物:取得7項化學發光類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661210916?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 16:14","pubTimestamp":1787472844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","MDEV","AGNG","PTH","RSPH","HART","IEIH","LGHT","LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212103","title":"翔宇醫療激光毫米波治療儀獲國家醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212103?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 08:00","pubTimestamp":1787443259,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","RSPH","IEIH","GDOC","LGHT","MEDX","HART","PTH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661265431","title":"貴州公布13起典型案例","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265431","media":"贵阳日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661265431?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 16:37","pubTimestamp":1787301420,"startTime":"0","endTime":"0","summary":"为发挥警示教育作用,现选取部分案例予以公布。经向备案机关核验,确认涉案备案凭证系伪造国家机关公文,当事人行为已涉嫌刑事犯罪。当事人案发后及时整改并完成退费,无同类处罚记录。依据《中华人民共和国消费者权益保护法实施条例》第五十条第一款规定,责令当事人改正违法行为,并处罚款的行政处罚。当事人共销售 7 盒涉案产品,货值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-21/doc-inipakur8157728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PTH","BK1583","IEIH","RSPH","AGNG","MEDX","GDOC","BK1574","LNGR","HART","LGHT","BK1100","09996","MDEV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}